X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (498) 498
index medicus (433) 433
multiple myeloma (360) 360
hematology (342) 342
oncology (299) 299
diagnosed multiple-myeloma (285) 285
stem-cell transplantation (270) 270
newly-diagnosed myeloma (258) 258
multiple myeloma - drug therapy (235) 235
bortezomib (219) 219
male (199) 199
female (196) 196
middle aged (181) 181
aged (180) 180
thalidomide (172) 172
multiple myeloma - therapy (169) 169
treatment outcome (157) 157
lenalidomide (150) 150
antineoplastic combined chemotherapy protocols - therapeutic use (138) 138
chemotherapy (137) 137
transplantation (137) 137
adult (136) 136
thalidomide - analogs & derivatives (124) 124
dexamethasone (119) 119
therapy (112) 112
multiple myeloma - mortality (111) 111
care and treatment (105) 105
cancer (103) 103
antineoplastic agents - therapeutic use (102) 102
survival (102) 102
lenalidomide plus dexamethasone (92) 92
autologous transplantation (90) 90
transplantation, autologous (88) 88
plus dexamethasone (84) 84
stem cells (83) 83
thalidomide - administration & dosage (83) 83
combination therapy (82) 82
myeloma (82) 82
prognosis (80) 80
elderly-patients (78) 78
thalidomide - therapeutic use (78) 78
dexamethasone - administration & dosage (70) 70
thalidomide plus dexamethasone (70) 70
aged, 80 and over (69) 69
high-dose therapy (69) 69
stem cell transplantation (69) 69
melphalan (68) 68
disease-free survival (66) 66
hematology, oncology and palliative medicine (66) 66
multiple myeloma - diagnosis (66) 66
immunology (64) 64
risk factors (64) 64
survival analysis (63) 63
multiple myeloma - pathology (61) 61
drug therapy (60) 60
hematopoietic stem cell transplantation (60) 60
trial (60) 60
retrospective studies (59) 59
clinical trials as topic (55) 55
health aspects (55) 55
boronic acids - administration & dosage (54) 54
thalidomide - adverse effects (54) 54
pyrazines - administration & dosage (53) 53
research (53) 53
antineoplastic agents - adverse effects (51) 51
antineoplastic combined chemotherapy protocols - adverse effects (51) 51
randomized-trial (51) 51
bone-marrow-transplantation (50) 50
patients (50) 50
abridged index medicus (48) 48
analysis (47) 47
combined modality therapy (47) 47
article (46) 46
newly diagnosed (46) 46
pharmacology & pharmacy (46) 46
maintenance therapy (45) 45
prednisone (45) 45
medicine, general & internal (44) 44
term-follow-up (44) 44
hematopoietic stem cell transplantation - methods (43) 43
antineoplastic agents - administration & dosage (42) 42
randomized controlled-trial (41) 41
diagnosis (39) 39
hematopoietic stem cells (39) 39
multiple myeloma - complications (39) 39
patient outcomes (39) 39
remission induction (39) 39
survival rate (39) 39
animals (38) 38
cyclophosphamide (37) 37
clinical trials (36) 36
boronic acids - therapeutic use (35) 35
induction therapy (35) 35
minimal residual disease (35) 35
pegylated liposomal doxorubicin (35) 35
pyrazines - therapeutic use (35) 35
medicine & public health (34) 34
recurrence (34) 34
dosage and administration (33) 33
multiple myeloma - surgery (33) 33
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (657) 657
French (9) 9
Spanish (4) 4
Japanese (2) 2
Polish (2) 2
Chinese (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 08/2011, Volume 8, Issue 8, pp. 479 - 491
Journal Article
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 11/2015, Volume 13, Issue 11, pp. 1398 - 1435
Multiple myeloma (MM) is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. Recent statistics... 
SINGLE-AGENT CARFILZOMIB | DONOR LYMPHOCYTE INFUSIONS | THALIDOMIDE PLUS DEXAMETHASONE | INDUCTION THERAPY | ONCOLOGY | HIGH-DOSE THERAPY | LONG-TERM SURVIVAL | NEWLY-DIAGNOSED MYELOMA | PHASE-III | NATIONAL-CANCER-INSTITUTE | STEM-CELL TRANSPLANTATION
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 21, pp. 2133 - 2142
Journal Article
Nature Reviews Disease Primers, ISSN 2056-676X, 07/2017, Volume 3, Issue 1, p. 17047
Multiple myeloma is a malignancy of terminally differentiated plasma cells, and patients typically present with bone marrow infiltration of clonal plasma cells... 
MEDICINE, GENERAL & INTERNAL | HIGH-RISK CYTOGENETICS | RESISTANCE CAM-DR | NEWLY-DIAGNOSED PATIENTS | ATOMIC-BOMB SURVIVORS | INTERNATIONAL STAGING SYSTEM | LENALIDOMIDE PLUS DEXAMETHASONE | UNDETERMINED SIGNIFICANCE | QUALITY-OF-LIFE | STEM-CELL TRANSPLANTATION | GENOME-WIDE ASSOCIATION
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 11/2006, Volume 1, Issue 6, pp. 1322 - 1330
Journal Article